Host: |
Rabbit |
Applications: |
WB/IF/ICC/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:2000IF/ICC:1:50-1:100ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
ASPA |
Gene ID: |
443 |
Uniprot ID: |
ACY2_HUMAN |
Immunogen Region: |
1-313 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-313 of human ASPA (NP_001121557.1). |
Immunogen Sequence: |
MTSCHIAEEHIQKVAIFGGT HGNELTGVFLVKHWLENGAE IQRTGLEVKPFITNPRAVKK CTRYIDCDLNRIFDLENLGK KMSEDLPYEVRRAQEINHLF GPKDSEDSYDIIFDLHNTTS NMGCTLILEDSRNNFLIQMF HYIKTSLAPLPCYVYLIEHP SLKYATTRSIAKYPVGIEVG PQPQGVLRADILDQMRKMIK HALDFIHHFNEGKEFPPCAI EVYKIIEKVDYPRDENGEI |
Tissue Specificity | Brain white matter, skeletal muscle, kidney, adrenal glands, lung and liver. |
Function | Catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids. |
Protein Name | AspartoacylaseAminoacylase-2Acy-2 |
Database Links | Reactome: R-HSA-8963693 |
Cellular Localisation | CytoplasmNucleus |
Alternative Antibody Names | Anti-Aspartoacylase antibodyAnti-Aminoacylase-2 antibodyAnti-Acy-2 antibodyAnti-ASPA antibodyAnti-ACY2 antibodyAnti-ASP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance